DEA Eases Rules for Opioid Recovery Medications
Published Date: 6/9/2026
Rule
Summary
Starting July 9, 2026, new rules make it easier for doctors and pharmacies to provide medicine that helps people recover from opioid addiction. These changes affect healthcare providers by expanding who can give medication-assisted treatment and how pharmacies can deliver these medicines. The goal? Faster, safer access to treatment with clear rules that save time and support recovery.
Analyzed Economic Effects
5 provisions identified: 3 benefits, 2 costs, 0 mixed.
No Federal Patient Caps for MAT
Starting July 9, 2026, there is no longer a federal limit on how many patients a practitioner may treat for maintenance or detoxification without separate Narcotic Treatment Program registration. This removes the prior patient-number caps that had limited how many people a single provider could treat.
Pharmacies Can Deliver MAT Drugs to Providers
Pharmacies may deliver certain FDA‑approved Schedule III–V medications for maintenance or detoxification directly to the prescribing or administering practitioner's DEA-registered location for administration to a named patient. This delivery option is intended to help patients get treatment where the practitioner can give the medication directly.
Administration Window Extended to 45 Days
The rule implements the statutory change that a controlled substance delivered by a pharmacy to an administering practitioner must be administered to the named patient within 45 days of receipt (changed from 14 days). This change was made by the Omnibus and is adopted in this final rule.
Administering Practitioner Must Hold Individual DEA Registration
The rule requires that the administering practitioner be individually registered with DEA under 21 U.S.C. 823(g) to dispense and must act within the scope of that registration. DEA declined to expressly list pharmacists as administering practitioners and notes that only in a limited number of states are pharmacists individually registered with DEA to administer controlled substances.
One-Time Training Requirement for Registrants
Under the rule, any qualified practitioner (not solely veterinarians) who first applies for or renews a DEA registration to dispense controlled substances in schedules II–V on or after June 27, 2023, must satisfy a one-time training requirement. The training is a statutory condition of receiving a DEA registration or renewal.
Your PRIA Score
Personalized for You
How does this regulation affect your finances?
Sign up for a PRIA Policy Scan to see your personalized alignment score for this federal register document and every other regulation we track. We analyze your financial profile against policy provisions to show you exactly what matters to your wallet.
Key Dates
Department and Agencies
Related Federal Register Documents
2026-10128 — Revision of Applications for Manufacturing and Procurement Quotas
The DEA wants to update how companies apply for permission to make and buy certain controlled drugs and chemicals. These changes will make the rules clearer, help prevent drug shortages, and ensure enough supply for medical and scientific needs. If you’re a manufacturer or involved in this process, get ready to follow new steps and share your thoughts by July 20, 2026.
2026-11572 — Ashley Vermillion, N.P.; Decision and Order
Ashley Vermillion, a nurse practitioner from Maine, lost her DEA registration because she no longer has the legal right to handle controlled substances in her state. She didn’t ask for a hearing, so the DEA moved forward and officially revoked her registration. This means she can’t prescribe or manage controlled drugs anymore, effective immediately.
2026-11416 — Importer of Controlled Substances Application: CalCog Inc.
CalCog Inc. wants to become an official importer of some powerful controlled substances like LSD and 5-MeO-DMT. People and companies involved with these drugs have until July 8, 2026, to share their thoughts or ask for a hearing. This move could shake up the import scene, but no costs or changes happen until the DEA decides.
2026-10380 — Schedules of Controlled Substances: Placement of Diphenidine in Schedule I
The DEA wants to put diphenidine, a drug, into Schedule I, which means it will be treated like the most tightly controlled substances. This change affects anyone who makes, sells, studies, or owns diphenidine, adding strict rules and penalties. You’ve got until June 25, 2026, to share your thoughts before the new rules might kick in.
2026-10253 — Schedules of Controlled Substances: Temporary Placement of 2-Fluorodeschloroketamine in Schedule I
Starting May 22, 2026, the DEA is putting 2-fluorodeschloroketamine (2-FDCK) into Schedule I, meaning it’s now treated like the most dangerous drugs. This affects anyone who makes, sells, or uses it, adding strict rules and serious penalties. The temporary ban lasts two years, giving the government time to decide if it should stay permanent.
2026-10090 — Exempt Chemical Preparations Under the Controlled Substances Act
The Drug Enforcement Administration (DEA) reviewed and decided on applications for special chemical mixtures that don’t fall under strict drug rules, covering requests from July 2025 to March 2026. Some mixtures got approved, others denied, and a few listings were fixed from earlier notices. If you’re involved with these chemicals, you’ve got until July 20, 2026, to share your thoughts—no fees or big costs involved, just your voice!
Previous / Next Documents
Previous: 2026-11513 — Schedule of Fees for Consular Services, Department of State and Overseas Embassies and Consulates-Visa and Citizenship Services Fee Changes
Starting July 1, 2026, travelers applying for a B1/B2 business or tourist visa can pay an extra $750 to get a faster interview appointment—within 10 business days—at select U.S. embassies and consulates. This new optional fee is temporary and runs through December 31, 2026. If you want quicker service, be ready to pay up and act fast, as spots are limited!
Next: 2026-11528 — Airworthiness Directives; Pilatus Aircraft Ltd. Airplanes
Pilatus PC-12/47E airplane owners need to update their stall warning system software and add a temporary pilot handbook revision by July 14, 2026. This fix stops the stall warning from going off at the wrong times, keeping flights safer. The FAA also bans installing the old, faulty software, so pilots should act fast to avoid any trouble or extra costs.